Details

NameSymbolSector
AMERISE BIOSCIENCES LIMITEDAMERISEPlastic Products - Industrial
Open
0.71
High
0.71
Low
0.65
Close
0.66
Volume
25437
Exchange
bse
Time
15-Jun-2026

Outlook

Score:  

1.75

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Amerise Biosciences is  
Opening Marubozu
Estimated Stoploss of Amerise Biosciences is ₹  
0.71
Amerise Biosciences has a  
Bearishℹ
 pattern. 
Formation of  
Opening Marubozu
 candle pattern indicates Amerise Biosciences has chances of  
Continuationℹ
 of the current trend. 

Trend

Amerise Biosciences is in  
Sideways trendℹ
. 
Price of Amerise Biosciences is  
Downℹ
 by  

2.94

%. 
Target
Buy @ 

0.62

Sell @ 

0.78

Current @ 

0.66

Volume

The trade volumes of Amerise Biosciences have become  
Deficientℹ
The volume trend for Amerise Biosciences is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Amerise Biosciences is  

Down

 by  

61.22

% 

Valuation

The current market price of Amerise Biosciences is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 8cr and total assets worth ₹ 8cr, the balance sheet of Amerise Biosciences is:  
Balancedℹ
. 
Cashflow
Amerise Biosciences has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

50% i.e. ₹ 3cr earned in operatingℹ
50% i.e. ₹ 3cr spent in investingℹ
0% in financingℹ
0% in otherℹ
Income
The income of Amerise Biosciences is  

₹ 0cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2025)

Amerise Biosciences Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Sep 2025)

The income of Amerise Biosciences is  

₹ 0cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Amerise Biosciences Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Jun 2025)

The income of Amerise Biosciences is  

₹ 0cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Amerise Biosciences Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.